Emerging targets and therapeutic approaches for the treatment of osteoarthritis pain
- PMID: 25730180
- DOI: 10.1097/SPC.0000000000000125
Emerging targets and therapeutic approaches for the treatment of osteoarthritis pain
Abstract
Purpose of review: Osteoarthritis is a complex and often painful disease that is inadequately controlled with current analgesics. This review discusses emerging targets and therapeutic approaches that may lead to the development of better analgesics.
Recent findings: Aberrant excitability in peripheral and central pain pathways drives osteoarthritis pain, reversing this via modulation of nerve growth factor, voltage-gated sodium channel, voltage-gated calcium channel and transient receptor potential vanilloid one activity, and increasing inhibitory mechanisms through modulation of cannabinoid and descending modulatory systems hold promise for osteoarthritis pain therapy. Somatosensory phenotyping of chronic pain patients, as a surrogate of putative pain generating mechanisms, may predict patient response to treatment.
Summary: Identification of new targets will inform and guide future research, aiding the development of more effective analgesics. Future clinical trial designs should implement sensory phenotyping of patients, as an inclusion or stratification criterion, in order to establish an individualized, mechanism-based treatment of osteoarthritis pain.
Similar articles
-
Pain: nonmalignant disease.Curr Opin Support Palliat Care. 2015 Jun;9(2):122-3. doi: 10.1097/SPC.0000000000000138. Curr Opin Support Palliat Care. 2015. PMID: 25872122 No abstract available.
-
Emerging potassium channel targets for the treatment of pain.Curr Opin Support Palliat Care. 2015 Jun;9(2):147-54. doi: 10.1097/SPC.0000000000000131. Curr Opin Support Palliat Care. 2015. PMID: 25872119 Review.
-
Elucidation of pathophysiology and treatment of neuropathic pain.Cent Nerv Syst Agents Med Chem. 2012 Dec;12(4):304-14. doi: 10.2174/187152412803760645. Cent Nerv Syst Agents Med Chem. 2012. PMID: 23033930 Review.
-
Peripheral Mechanisms Contributing to Osteoarthritis Pain.Curr Rheumatol Rep. 2018 Feb 26;20(2):9. doi: 10.1007/s11926-018-0716-6. Curr Rheumatol Rep. 2018. PMID: 29480410 Free PMC article. Review.
-
Neuropathic pain: preclinical and early clinical progress with voltage-gated sodium channel blockers.Expert Opin Investig Drugs. 2020 Mar;29(3):259-271. doi: 10.1080/13543784.2020.1728254. Epub 2020 Feb 19. Expert Opin Investig Drugs. 2020. PMID: 32070160 Review.
Cited by
-
Phenotypic Characterization of Paclitaxel-Induced Peripheral Neuropathy in Cancer Survivors.J Pain Symptom Manage. 2018 Dec;56(6):908-919.e3. doi: 10.1016/j.jpainsymman.2018.08.017. Epub 2018 Aug 30. J Pain Symptom Manage. 2018. PMID: 30172061 Free PMC article.
-
Development of monosodium acetate-induced osteoarthritis and inflammatory pain in ageing mice.Age (Dordr). 2015 Jun;37(3):9792. doi: 10.1007/s11357-015-9792-y. Epub 2015 May 14. Age (Dordr). 2015. PMID: 25971876 Free PMC article.
-
Chromenopyrazole, a Versatile Cannabinoid Scaffold with in Vivo Activity in a Model of Multiple Sclerosis.J Med Chem. 2016 Jul 28;59(14):6753-6771. doi: 10.1021/acs.jmedchem.6b00397. Epub 2016 Jul 6. J Med Chem. 2016. PMID: 27309150 Free PMC article.
-
Chemotherapy-Induced Neuropathy in Cancer Survivors.J Pain Symptom Manage. 2017 Aug;54(2):204-218.e2. doi: 10.1016/j.jpainsymman.2016.12.342. Epub 2017 Jan 4. J Pain Symptom Manage. 2017. PMID: 28063866 Free PMC article.
-
Therapeutic Controlled Release Strategies for Human Osteoarthritis.Adv Healthc Mater. 2025 Jan;14(2):e2402737. doi: 10.1002/adhm.202402737. Epub 2024 Nov 6. Adv Healthc Mater. 2025. PMID: 39506433 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
